BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29050968)

  • 1. Discovery and electrophysiological characterization of SKF-32802: A novel hERG agonist found through a large-scale structural similarity search.
    Donovan BT; Bandyopadhyay D; Duraiswami C; Nixon CJ; Townsend CY; Martens SF
    Eur J Pharmacol; 2018 Jan; 818():306-327. PubMed ID: 29050968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol inhibits hERG K
    Han SN; Jing Y; Yang LL; Zhang Z; Zhang LR
    Eur J Pharmacol; 2016 Nov; 791():168-178. PubMed ID: 27575519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HERG potassium channels by domiphen bromide and didecyl dimethylammonium bromide.
    Long Y; Chen W; Lin Z; Sun H; Xia M; Zheng W; Li Z
    Eur J Pharmacol; 2014 Aug; 737():202-9. PubMed ID: 24846011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel.
    Mannikko R; Bridgland-Taylor MH; Pye H; Swallow S; Abi-Gerges N; Morton MJ; Pollard CE
    Br J Pharmacol; 2015 Jun; 172(12):3112-25. PubMed ID: 25684549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
    Larsen AP; Olesen SP; Grunnet M; Poelzing S
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
    Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use-dependent 'agonist' effect of azimilide on the HERG channel.
    Jiang M; Dun W; Fan JS; Tseng GN
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1324-36. PubMed ID: 10565858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
    Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
    Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids and hERG channels: Friends or foes?
    Saponara S; Fusi F; Iovinelli D; Ahmed A; Trezza A; Spiga O; Sgaragli G; Valoti M
    Eur J Pharmacol; 2021 May; 899():174030. PubMed ID: 33727059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
    Schuster AM; Glassmeier G; Bauer CK
    Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
    Bilet A; Bauer CK
    PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
    Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
    Gerlach AC; Stoehr SJ; Castle NA
    Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca
    Fusi F; Trezza A; Spiga O; Sgaragli G; Bova S
    Biochem Pharmacol; 2017 Sep; 140():53-63. PubMed ID: 28583845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
    Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
    J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channel sialic acids limit hERG channel activity during the ventricular action potential.
    Norring SA; Ednie AR; Schwetz TA; Du D; Yang H; Bennett ES
    FASEB J; 2013 Feb; 27(2):622-31. PubMed ID: 23139156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.